Inotiv Inc (NOTV)

Healthcare | Medical Diagnostics Research
Income Statement (Quarterly) 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Revenue 124,323,000 119,876,000 130,417,000 105,786,000
Cost of Revenue 95,332,000 94,838,000 100,478,000 84,705,000
Gross Profit 28,991,000 25,038,000 29,939,000 21,081,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 22,230,000 24,289,000 25,631,000 21,812,000
Operating Expenses 31,929,000 40,545,000 43,106,000 41,833,000
Operating Income -2,938,000 -15,507,000 -13,167,000 -20,752,000
Interest Expense 13,446,000 13,838,000 12,316,000 12,116,000
Income Before Tax -15,976,000 -29,808,000 -24,045,000 -32,950,000
Income Tax Expense 1,110,000 -2,178,000 -5,154,000 -6,863,000
Net Income -14,866,000 -27,630,000 -18,891,000 -26,087,000
Per Share
EPS -0.44 -1.02 3.44 -1.00
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Revenue 513,024,000 490,739,000 572,425,000 547,656,000 89,605,000
Cost of Revenue 447,972,000 379,568,000 406,982,000 390,444,000 59,449,000
Gross Profit 65,052,000 111,171,000 165,443,000 157,212,000 30,156,000
Operating Expenses
R&D Expenses 0 0 0 0 0
SG&A Expenses 92,244,000 97,917,000 127,318,000 99,086,000 33,892,000
Operating Expenses 95,954,000 197,577,000 246,903,000 184,659,000 35,774,000
Operating Income -30,902,000 -86,406,000 -81,460,000 -27,447,000 -5,618,000
Interest Expense 56,593,000 46,884,000 43,019,000 29,704,000 1,683,000
Income Before Tax -87,768,000 -130,760,000 -124,242,000 -352,449,000 6,119,000
Income Tax Expense -19,143,000 -21,875,000 -19,340,000 -15,187,000 -4,776,000
Net Income -68,625,000 -108,445,000 -105,140,000 -337,262,000 10,895,000
Per Share
EPS -2.11 -4.19 -4.10 -13.85 0.83
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Assets
Cash and Cash Equivalents 21,741,000 21,432,000 35,492,000 18,515,000
Short Term Investments 0 0 0 0
Net Receivables 78,222,000 77,442,000 90,422,000 100,073,000
Inventory 45,738,000 18,173,000 56,102,000 71,441,000
Total Current Assets 194,591,000 163,413,000 213,803,000 232,977,000
Property Plant Equipment 227,084,000 237,493,000 229,934,000 218,688,000
Goodwill and Intangibles 334,483,000 368,682,000 402,714,000 503,711,000
Total Assets 771,114,000 781,361,000 856,530,000 962,900,000
Liabilities
Account Payables 48,531,000 33,526,000 32,564,000 28,695,000
Short Term Debt 409,019,000 15,312,000 18,232,000 30,961,000
Total Current Liabilities 556,784,000 119,042,000 132,194,000 164,099,000
Long Term Debt 44,344,000 429,811,000 399,409,000 355,531,000
Total Liabilities 635,086,000 610,857,000 588,040,000 603,134,000
Shareholders Equity
Retained Earnings -630,813,000 -562,163,000 -453,278,000 -348,277,000
Total Shareholders Equity 136,028,000 170,504,000 269,154,000 360,372,000
Balance Sheet (Annual) 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Assets
Cash and Cash Equivalents 21,741,000 21,432,000 35,492,000 18,515,000 138,924,000
Short Term Investments 0 0 0 0 0
Net Receivables 78,222,000 77,442,000 90,422,000 100,073,000 28,364,000
Inventory 45,738,000 18,173,000 56,102,000 71,441,000 602,000
Total Current Assets 194,591,000 163,413,000 213,803,000 232,977,000 189,019,000
Property Plant Equipment 227,084,000 237,493,000 229,934,000 218,688,000 56,396,000
Goodwill and Intangibles 334,483,000 368,682,000 402,714,000 503,711,000 76,160,000
Total Assets 771,114,000 781,361,000 856,530,000 962,900,000 321,856,000
Liabilities
Account Payables 48,531,000 33,526,000 32,564,000 28,695,000 6,163,000
Short Term Debt 409,019,000 15,312,000 18,232,000 30,961,000 13,388,000
Total Current Liabilities 556,784,000 119,042,000 132,194,000 164,099,000 55,109,000
Long Term Debt 44,344,000 429,811,000 399,409,000 355,531,000 160,802,000
Total Liabilities 635,086,000 610,857,000 588,040,000 603,134,000 216,728,000
Shareholders Equity
Retained Earnings -630,813,000 -562,163,000 -453,278,000 -348,277,000 -11,015,000
Total Shareholders Equity 136,028,000 170,504,000 269,154,000 360,372,000 105,128,000
Cash Flow Statement (Quarterly) 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Operating Activities
Net Income -68,625,000 -108,885,000 -104,902,000 -337,262,000
Depreciation & Amortization 55,928,000 57,118,000 54,717,000 49,324,000
Stock Based Compensation 6,028,000 6,740,000 7,844,000 24,202,000
Change in Working Capital -1,144,000 52,604,000 16,956,000 -40,277,000
Operating Cash Flow -10,455,000 -6,805,000 27,883,000 -5,217,000
Investing Activities
Capital Expenditure -16,615,000 -22,310,000 -27,503,000 -36,300,000
Investments -16,615,000 -22,310,000 -27,503,000 -36,300,000
Investing Cash Flow -12,891,000 -16,832,000 -28,755,000 -333,722,000
Financing Activities
Debt Repayment -1,945,000 13,546,000 -25,161,000 -59,743,000
Common Stock Issued/Repurchased 27,524,000 0 110,000 118,000
Dividends Paid 0 0 0 0
Financing Cash Flow 23,701,000 9,675,000 15,872,000 203,151,000
Summary
Free Cash Flow -27,070,000 -29,115,000 380,000 -41,517,000
Net Change in Cash 309,000 -14,060,000 16,512,000 -137,944,000
Cash Flow Statement (Annual) 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Operating Activities
Net Income -68,625,000 -108,885,000 -104,902,000 -337,262,000 10,895,000
Depreciation & Amortization 55,928,000 57,118,000 54,717,000 49,324,000 6,268,000
Stock Based Compensation 6,028,000 6,740,000 7,844,000 24,202,000 1,786,000
Change in Working Capital -1,144,000 52,604,000 16,956,000 -40,277,000 9,643,000
Operating Cash Flow -10,455,000 -6,805,000 27,883,000 -5,217,000 10,746,000
Investing Activities
Capital Expenditure -16,615,000 -22,310,000 -27,503,000 -36,300,000 -12,472,000
Investments -16,615,000 -22,310,000 -27,503,000 -36,300,000 0
Investing Cash Flow -12,891,000 -16,832,000 -28,755,000 -333,722,000 -54,060,000
Financing Activities
Debt Repayment -1,945,000 13,546,000 -25,161,000 -59,743,000 -4,639,000
Common Stock Issued/Repurchased 27,524,000 0 110,000 118,000 48,971,000
Dividends Paid 0 0 0 0 0
Financing Cash Flow 23,701,000 9,675,000 15,872,000 203,151,000 198,832,000
Summary
Free Cash Flow -27,070,000 -29,115,000 380,000 -41,517,000 -1,726,000
Net Change in Cash 309,000 -14,060,000 16,512,000 -137,944,000 155,518,000